We chose to use A549 (human lung carcinoma) cells for this analysis, as they can be efficiently infected with CHIKV [40] (Figure S2), are known to be immune-competent [41], and respond well to exogenous (e.g., TNFα) activation of the NF-κB pathway (Figure S3). The gene discussed is NFKB1; the disease is lung carcinoma.